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The aim of the study was to investigate the biological effects 
in human lymphocytes irradiated with the 60 MeV proton 
beam in the Bronowice Cyclotron Center IFJ PAN. The 
relative biological effectiveness (RBE) of the proton beam in 
comparison to X-ray’s was estimated by the comet method. 
Whole blood samples were collected from 5 healthy donors. 
For dose-response studies lymphocytes were used submerged 
in agarose on microscopic slides, set in a specially designed 
PMMA phantom located at the isocenter. Cells were irradiated 
in Eppendorf vessels located in the mead of Spread-Out Bragg 
Peak (SOBP) in the fully modulated proton beam with range 
of 29 mm. 
For reference, the lymphocytes were exposed to the 250 kV 
X-rays. For both sources of radiations, dose-effect curves at a 
dose range (0-4Gy) were estimated. The level of DNA damage 
was assessed using the alkaline version of comet assay, also 
called the DNA single cell gel electrophoresis (SCGE). 
The obtained dose-response relationships for the level of DNA 
damage showed linear character for both sources of radiation 
(R2 = 0.994 for protons and R2 = 0.995 for X-rays). The 
efficiency of protons in inducing DNA strand breaks for the 
dose range from 0.3 to 4 Gy calculated as the ratio of the 
two α coefficients was 1.37. The average RBE calculated 
from the proton and X-ray dose required for the iso-effective 
TDNA comet assay parameter was 1.51 + / - 0.05 (range 1.45-
1.66).  
This observation suggests that the standard alkaline comet 
assay is reliable technique for estimation of DNA damage 
caused by proton and X-ray radiation in vitro. 
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Presently for production of medical radionuclides the 
cyclotrons are widely used which are very safe and reliable 
installations. At PNPI a high current cyclotron C-80 with the 
energy of extracted proton beam of 40-80 MeV and the 
current up to 200 μA has been constructed. One of the main 
goals of C-80 is production of a wide spectrum of medical 
radio-nuclides for diagnostics and therapy. At the beam of C-
80 the project of radioisotope complex RIC-80 (Radio Isotopes 
at the cyclotron C-80) has been worked out. In the presented 
submission the project of RIC-80 complex is discussed, which 
includes three target stations for production of radio-nuclides 
for medicine. The peculiarity of the proposed radio-isotope 
facility is the use of the mass-separator with the target-ion 
source device as one of the target stations for on-line, or 
semi on-line production of a high purity separated radio-
nuclides. The results on the target development for 
production of radio-isotope generator for PET diagnostics 82Sr 
are presented. 
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Purpose: Epithelial–mesenchymal transition (EMT) allows 
tumor cells to acquire the capacity to infiltrate surrounding 
tissue and to ultimately metastasize to distant sites. Limited 
information is available on the regulation of EMT in cervical 
cancer. Epidermal growth factor (EGF) has beenreported as a 
potent stimulator of cervical cancer invasiveness. 
Upregulation of epidermal growth factor receptor (EGFR) 
expression is reported in the recurrent cervical cancer. Fused 
Toes Homolog (FTS) has been reported as a general regulator 
of AKT activity in the control of differentiation, proliferation, 
and apoptosis in many cell types. Importantly, studies from 
our laboratory have shown overexpression of FTS in cervical 
cancer specimens and the expression of this protein increases 
with advancement of the disease. Hence, we studied the role 
of FTS in EGF-induced EMT in cervical cancer cells. 
Materials and Methods: A human cervical carcinoma cell line 
ME180 was used. Gene silencing was obtained using siRNA. 
Protein expression was studied by Western blot and 
immunofluorescence. Cell migration and invasion was 
assessed by wound healing and matrigel migration assay.  
Results: EGF treatment induced the change of EMT markers 
and increased cell migration. EGF treatment also increased 
phosphorylated EGFR and ERK and nuclear level of ATF-2. 
The binding of ATF-2 to the promoter region of FTS was 
evidenced after EGF treatment. Pretreatment with PD98059 
and gefitinib prevented EGF-induced FTS expression. FTS-
silencing reduced EMT and cell migration by EGF treatment. 
Conclusions: These results suggest that upregulation of FTS 
by EGF is mediated via EGF/EGFR/ERK/ATF-2 and this 
facilitates EGF-mediated EMT process in cervical cancer 
cells. FTS can be a potential target to circumvent cervical 
cancer progression driven by EGF. 
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Purpose: In PET-based treatment verification the low 
counting statistics PET data acquired during/after the 
treatment (Measured PET) must be compared to a Monte 
Carlo estimate of the β+ distribution induced by the 
treatment (Expected PET) based on the planning Computed 
Tomography (CT) images [1]. Given the extremely low quality 
of Measured PET images and the consequent difficulties in 
mismatch estimation, we proposed to use a 4D Maximum 
Likelihood (ML) reconstruction strategy considering Expected 
PET and Measured PET as two frames of a 4D dataset and 
providing an estimate of the motion field mapping one frame 
to the other [2]. 
The aim of this work is to optimize the strategy on a 
